Amneal Pharmaceuticals, Inc. (AMRX) has a market capitalization of $4.13B and trades at $13.12. The 52-week range is 6.685-15.42.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 57, Earnings Per Share (EPS) of $0.23, annual revenue of $3.02B.
The stock has a beta of 1.32, operates in the Healthcare sector.
